Predict to prevent pre-eclampsia

PerkinElmer’s DELFIA® Xpress PlGF 1-2-3 assay, used in the ground-breaking ASPRE study (Rolnik et al, 2017), is the most sensitive first trimester screening assay for pre-eclampsia to date. Screening with DELFIA® Xpress PlGF 1-2-3 assay before 13+6 weeks of gestation in combination with other biophysical markers and established risk factors, high risk women that are likely to develop preterm pre-eclampsia later in their pregnancy can be identified.

Aid in Diagnosis of Pre-eclampsia in the 2nd and 3rd trimester


During second and third trimesters of pregnancy, the DELFIA® Xpress sFlt-1 kit can be used for predicting the onset of pre-eclampsia and to manage pre-eclampsia in combination with the PlGF 1-2-3 assay as a ratio of concentrations and with other clinical factors.


In addition to DELFIA® Xpress, the PlGF 1-2-3 assay is also available for PerkinElmer’s AutoDELFIA® and Victor2™ D platforms. PerkinElmer’s biochemistry assays and supporting instruments are complemented by essential items such as human serum controls to ensure the integrity of results. We also supply dedicated pre-eclampsia screening software for risk calculations. Together, these products constitute a complete solution for pre-eclampsia management.

Products may not be licensed in accordance with the laws in all countries, such as the United States. Please check with your local representative for availability.

Products & Services (4)

Sort by

1-4 of 4 Products & Services

  • Victor_ND_0312_320px

    VICTOR2 D Instrument

    The VICTOR2™ D fluorometer is designed for all PerkinElmer diagnostic and screening assays based on either time-resolved fluorescence or prompt fluorescence. VICTOR2 D includes MultiCalc software for assay evaluation and quality control.
  • AutoDELFIA-L3A5093

    AutoDELFIA® immunoassay system for prenatal screening

    AutoDELFIA® immunoassay system for prenatal screening is supported by the widest available range of prenatal analytes available on any platform. Reliable and easy to use AutoDELFIA instrument offers high quality results both for aneuploidy and pre-eclampsia risk assessment during pregnancy.
  • sFlt-1_kits

    DELFIA® Xpress sFlt-1 kit

    The kit is intended for the quantitative determination of soluble Fms-like tyrosine kinase-1 (sFlt-1) in maternal serum using the 6000 DELFIA® Xpress random access immunoanalyzer.
  • sFlt-1 Controls

    sFlt-1 Controls

    sFlt-1 Controls are intended for use as assayed quality controls to monitor precision and validity of laboratory measurement procedures for the DELFIA® sFlt-1 assays.